查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1980183

眼科醫療設備市場規模、佔有率、成長率及全球產業分析：按類型、應用和地區的洞察，2026-2034年預測

Ophthalmic Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 150 Pages | 商品交期: 請詢問到貨日

價格

眼科醫療設備市場成長要素

全球眼科醫療設備市場預計在2025年達到314.5億美元，2026年成長至329億美元，並在2034年達到484.4億美元，預測期內年複合成長率（CAGR）為5%。2025年，北美市場佔據主導地位，市場佔有率達40.92%，這主要得益於先進人工水晶體（IOL）的普及、眼科手術量的激增以及主要市場參與者的強大影響力。

該市場涵蓋眼科診斷和手術器械，以及隱形眼鏡和眼部健康管理設備等視力保健產品。近視、高度近視、白內障、青光眼、糖尿病視網膜病變和老齡化黃斑部病變等視力障礙的日益普遍，推動全球需求成長。世界衛生組織（WHO）和布萊恩霍爾頓視覺研究所預測，到2050年，全球約 52%的人口將患有近視，10%的人口將患有高度近視，這凸顯了眼科器械日益成長的需求。

市場促進因素

視力障礙盛行率的不斷上升和眼科手術數量的增加是市場成長的主要促進因素。例如，2018年美國進行了約390萬例白內障手術，反映出對手術器械的需求日益成長。此外，微創青光眼手術（MIG）植入物和三焦點人工水晶體植入等技術的進步也進一步推動了市場成長。

其他促成因素包括有利的償付政策、人均醫療保健支出不斷成長以及患者眼部健康意識的提高。視力保健設備（尤其是隱形眼鏡）的普及率不斷提高，據估計，美國有4500萬人使用隱形眼鏡，為視力保健行業做出了重大貢獻。

市場限制因素

眼科設備的高成本限制了新興市場的成長。例如，飛秒雷射的價格在20萬至40萬美元之間，中小診所難以負擔。此外，新興市場醫療基礎設施不足、產品取得困難以及患者認知度低導致的治療率低等問題，也持續阻礙市場擴張。

新冠疫情的影響

新冠疫情對市場造成了負面影響，尤其是在外科領域，眼科手術數量大幅下降。一項針對美國228家醫院的分析顯示，2020年3月至4月期間，眼科就診量下降了81%，白內障手術量下降了97%。另一方面，由於封鎖措施引發的恐慌性購買和囤積，眼藥水等視力保健產品的需求卻增加。

細分分析

依產品：

  • 受隱形眼鏡和眼部保健產品使用量不斷增加的推動，視力保健設備正引領市場。
  • 隨著人工水晶體（IOL）技術的進步以及白內障和視網膜手術數量的增加，外科醫療設備也在不斷發展。例如，2019年，愛爾康公司在美國推出了AcrySof IQ PanOptix三焦點人工水晶體，這是一項意義重大的創新。

依最終用戶分類：

  • 由於等待時間短、引進先進設備等優勢，眼科診所佔了最大的市場佔有率。
  • 在「其他」領域（包括門診手術中心（ASC）和多專科診所），看到美國和歐洲的需求不斷成長。

區域趨勢

  • 北美：預計到2025年市場規模將達到 128.7億美元，到2026年將達到 134.6億美元，其中美國在2026年將佔 126.1億美元。這主要得益於先進人工水晶體的普及性和主要企業的強大影響力。
  • 歐洲：在政府投資和愛爾康公司推出的Vivity人工水晶體等創新產品的推動下，預計到2026年，英國市場將達到10.3億美元，德國將達到23.1億美元，這表明市場將顯著成長。
  • 亞太地區：由於白內障、青光眼和乾眼症的盛行率不斷上升，預計該地區將快速成長。預計到2026年，日本市場規模將達到27.7億美元，中國將達到37.1億美元，印度將達到7.3億美元。
  • 拉丁美洲、中東和非洲：市場佔有率的擴大和對隱形眼鏡日益成長的認知推動市場成長。

主要企業及產業趨勢

主要企業包括Alcon, Johnson & Johnson Vision Care, Inc., Bausch & Lomb Incorporated, Carl Zeiss Meditec, Cooper Companies, Inc., Essilor, Hoya Corporation, and NIDEK CO., LTD。這些公司致力於研發、產品創新和拓展業務區域，以鞏固其市場地位。

近期進展如下：

  • 2021年 7月：CooperVision在美國推出了「Clarity 1-day」，這是第一款淨塑膠中和的隱形眼鏡。
  • 2020年 11月：Alcon在2020年美國眼科學會虛擬會議上公佈了 AcrySof IQ Vivity人工水晶體的關鍵資料。
  • 2020年 9月：ZEISS International 推出了「ZEISS UVClean」，這是一款用於眼科診所的消毒設備。
  • 2020年 7月：HOYA 推出了「Sensity Fast」，這是一款對光線有反應的光致變色鏡片。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機會

第4章 主要考察

  • 2025年，產業主要發展趨勢 - 併購和合作
  • 主要眼科疾病的流行病學 - 依主要國家分類
  • 新產品引進/核准（由主要企業核准）
  • 主要國家監理趨勢概述
  • 眼科設備市場的技術進步

第5章 2021-2034年全球眼科醫療設備市場分析、洞察與預測

  • 主要發現與總結
  • 市場分析、洞察與預測：依產品類型分類
    • 外科
      • 植入
      • 消耗品
      • 裝置
    • 視力保健
      • 隱形眼鏡
      • 人工水晶體
  • 市場分析、洞察與預測：依最終用戶分類
    • 醫院
    • 眼科診所
    • 其他
  • 市場分析、洞察與預測：依地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美眼科醫療設備市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章 歐洲眼科醫療設備市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章 亞太地區眼科醫療設備市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章 拉丁美洲眼科醫療設備市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章 中東和非洲眼科醫療設備市場分析、洞察與預測（2021-2034年）

  • 國家
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 主要行業趨勢
  • 全球市場佔有率分析（2021）
  • 公司簡介
    • Alcon（Part of Novartis AG）
    • Johnson & Johnson Services, Inc.
    • Essilor
    • Bausch Health Companies
    • ZEISS International
    • HOYA
    • NIDEK CO., LTD
    • TOPCON
    • CooperVision
    • Other Prominent Players
Product Code: FBI102187

Growth Factors of ophthalmic devices Market

The global ophthalmic devices market was valued at USD 31.45 billion in 2025 and is projected to grow to USD 32.9 billion in 2026, reaching USD 48.44 billion by 2034, representing a CAGR of 5% during the forecast period. North America dominated the market in 2025 with a 40.92% share, driven by the widespread adoption of advanced intraocular lenses (IOLs), high volumes of ophthalmic surgeries, and a strong presence of major market players.

The market encompasses ophthalmic diagnostics and surgical devices, as well as vision care products such as contact lenses and ocular health devices. Increasing prevalence of vision disorders, including myopia, high myopia, cataracts, glaucoma, diabetic retinopathy, and age-related macular degeneration, is driving demand globally. According to the World Health Organization (WHO) and Brien Holden Vision Institute, by 2050, approximately 52% of the global population is expected to be affected by myopia and 10% by high myopia, highlighting the growing need for ophthalmic devices.

Market Drivers

The increasing prevalence of vision disorders, along with the rise in eye surgeries, is the primary driver for market growth. For instance, in the U.S., approximately 3.9 million cataract surgeries were performed in 2018, reflecting the growing demand for surgical devices. Additionally, technological advancements, such as the development of micro-invasive glaucoma (MIGs) surgical implants and trifocal intraocular lenses, have further propelled market growth.

Other drivers include favorable reimbursement policies, rising per capita healthcare expenditure, and increasing patient awareness of eye health. Vision care devices, particularly contact lenses, have seen higher adoption rates, with an estimated 45 million people in the U.S. using contact lenses, contributing significantly to the vision care segment.

Market Restraints

The high cost of ophthalmic devices limits growth in emerging countries. For example, femtosecond lasers cost between USD 200,000 and USD 400,000, making them less accessible to small and mid-sized clinics. Additionally, low treatment rates in emerging nations due to limited healthcare infrastructure, product accessibility, and patient awareness continue to restrain market expansion.

Impact of COVID-19

The COVID-19 pandemic negatively impacted the market, particularly the surgical segment, as ophthalmic procedures declined significantly. An analysis of 228 hospitals in the U.S. showed an 81% reduction in ophthalmology patient visits during March-April 2020, with cataract surgeries declining by 97%. Conversely, vision care devices such as eye-drops saw increased demand due to panic-buying and stockpiling amid lockdowns.

Segmentation Analysis

By Product:

  • Vision care devices dominate the market, driven by rising adoption of contact lenses and ocular health products.
  • Surgical devices are also growing due to innovations in intraocular lenses (IOLs) and the increasing number of cataract and retinal surgeries. For example, in 2019, Alcon launched the AcrySof IQ PanOptix Trifocal IOL, a key innovation in the U.S.

By End User:

  • Ophthalmic clinics hold the largest market share due to advantages such as shorter waiting times and adoption of advanced devices.
  • The others segment, including ambulatory surgical centers (ASCs) and multispecialty clinics, is witnessing growing demand in the U.S. and Europe.

Regional Insights

  • North America: Valued at USD 12.87 billion in 2025 and projected at USD 13.46 billion in 2026, with the U.S. accounting for USD 12.61 billion in 2026, fueled by advanced IOL adoption and a strong presence of key players.
  • Europe: Expected growth is significant, with the UK market projected at USD 1.03 billion and Germany at USD 2.31 billion in 2026, supported by government investments and innovative product launches like Alcon's Vivity IOL.
  • Asia Pacific: Rapid growth is projected due to rising incidence of cataract, glaucoma, and dry eye disease. The Japan market is projected at USD 2.77 billion, China at USD 3.71 billion, and India at USD 0.73 billion in 2026.
  • Latin America & Middle East/Africa: Market growth is driven by increasing manufacturer presence and rising awareness of contact lenses.

Key Players and Industry Developments

Leading companies include Alcon, Johnson & Johnson Vision Care, Inc., Bausch & Lomb Incorporated, Carl Zeiss Meditec, Cooper Companies, Inc., Essilor, Hoya Corporation, and NIDEK CO., LTD. These players are focused on R&D, product innovation, and geographical expansion to strengthen their market positions.

Recent developments include:

  • July 2021: CooperVision launched Clarity 1-day as the first net plastic-neutral contact lens in the U.S.
  • Nov 2020: Alcon presented pivotal data on AcrySof IQ Vivity IOL at the AAO 2020 virtual meeting.
  • Sept 2020: ZEISS International launched ZEISS UVClean disinfecting device for optometry clinics.
  • July 2020: Hoya launched Sensity Fast light-reactive lenses in the photochromic category.

Conclusion

The ophthalmic devices market is projected to grow from USD 31.45 billion in 2025 to USD 48.44 billion by 2034 at a CAGR of 5%, driven by rising prevalence of vision disorders, growing adoption of advanced devices, and increasing ophthalmic surgeries. While high device costs and low treatment rates in emerging nations remain challenges, technological advancements, innovative product launches, and expanding vision care awareness are expected to sustain market growth across all regions.

Segmentation By Product Type

  • Surgical
    • Implants
    • Consumables
    • Equipment
  • Vision Care
    • Contact Lens
    • Ocular Health

By End-user

  • Hospitals
  • Ophthalmic Clinics
  • Others

By Geography

  • North America
    • By Product
    • By End User
    • By Country
  • Europe
    • By Product
    • By End User
    • By Country/Sub-region
  • Asia Pacific
    • By Product
    • By End User
    • By Country/Sub-region
  • Latin America
    • By Product
    • By End User
    • By Country/Sub-region
  • The Middle East & Africa
    • By Product
    • By End User
    • By Country/Sub-region

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. Key Industry Developments - Mergers, Acquisitions, and Partnerships, 2025
  • 4.2. Epidemiology of Major Ocular Disease - For Key Countries
  • 4.3. Introduction of New Products / Approvals (by Major Players)
  • 4.4. Overview of Regulatory Scenario - Key Countries
  • 4.5. Technological Advancements in Ophthalmic Devices Market

5. Global Ophthalmic Devices Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Key Findings / Summary
  • 5.2. Market Analysis, Insights and Forecast - By Product Type
    • 5.2.1. Surgical
      • 5.2.1.1. Implants
      • 5.2.1.2. Consumables
      • 5.2.1.3. Equipment
    • 5.2.2. Vision Care
      • 5.2.2.1. Contact Lenses
      • 5.2.2.2. Intraocular Lenses
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Hospitals
    • 5.3.2. Ophthalmic Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Ophthalmic Devices Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Key Findings / Summary
  • 6.2. Market Analysis - By Product Type
    • 6.2.1. Surgical
      • 6.2.1.1. Implants
      • 6.2.1.2. Consumables
      • 6.2.1.3. Equipment
    • 6.2.2. Vision Care
      • 6.2.2.1. Contact Lenses
      • 6.2.2.2. Intraocular Lenses
  • 6.3. Market Analysis - By End-user
    • 6.3.1. Hospitals
    • 6.3.2. Ophthalmic Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Ophthalmic Devices Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Key Findings / Summary
  • 7.2. Market Analysis - By Product Type
    • 7.2.1. Surgical
      • 7.2.1.1. Implants
      • 7.2.1.2. Consumables
      • 7.2.1.3. Equipment
    • 7.2.2. Vision Care
      • 7.2.2.1. Contact Lenses
      • 7.2.2.2. Intraocular Lenses
  • 7.3. Market Analysis - By End-user
    • 7.3.1. Hospitals
    • 7.3.2. Ophthalmic Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis - By Country/ Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Ophthalmic Devices Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Key Findings / Summary
  • 8.2. Market Analysis - By Product Type
    • 8.2.1. Surgical
      • 8.2.1.1. Implants
      • 8.2.1.2. Consumables
      • 8.2.1.3. Equipment
    • 8.2.2. Vision Care
      • 8.2.2.1. Contact Lenses
      • 8.2.2.2. Intraocular Lenses
  • 8.3. Market Analysis - By End-user
    • 8.3.1. Hospitals
    • 8.3.2. Ophthalmic Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis - By Country/ Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Ophthalmic Devices Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Key Findings / Summary
  • 9.2. Market Analysis - By Product Type
    • 9.2.1. Surgical
      • 9.2.1.1. Implants
      • 9.2.1.2. Consumables
      • 9.2.1.3. Equipment
    • 9.2.2. Vision Care
      • 9.2.2.1. Contact Lenses
      • 9.2.2.2. Intraocular Lenses
  • 9.3. Market Analysis - By End-user
    • 9.3.1. Hospitals
    • 9.3.2. Ophthalmic Clinics
    • 9.3.3. Others
  • 9.4. Market Analysis - By Country/ Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Ophthalmic Devices Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Key Findings / Summary
  • 10.2. Market Analysis - By Product Type
    • 10.2.1. Surgical
      • 10.2.1.1. Implants
      • 10.2.1.2. Consumables
      • 10.2.1.3. Equipment
    • 10.2.2. Vision Care
      • 10.2.2.1. Contact Lenses
      • 10.2.2.2. Intraocular Lenses
  • 10.3. Market Analysis - By End-user
    • 10.3.1. Hospitals
    • 10.3.2. Ophthalmic Clinics
    • 10.3.3. Others
  • 10.4. Market Analysis - By Country/ Sub-region
    • 10.4.1. GCC Countries
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Key Industry Developments
  • 11.2. Global Market Share Analysis (2021)
  • 11.3. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.3.1. Alcon (Part of Novartis AG)
      • 11.3.1.1. Overview,
      • 11.3.1.2. Products,
      • 11.3.1.3. SWOT analysis,
      • 11.3.1.4. Recent developments,
      • 11.3.1.5. strategies,
      • 11.3.1.6. financials (based on availability)
    • 11.3.2. Johnson & Johnson Services, Inc.
      • 11.3.2.1. Overview,
      • 11.3.2.2. Products,
      • 11.3.2.3. SWOT analysis,
      • 11.3.2.4. Recent developments,
      • 11.3.2.5. strategies,
      • 11.3.2.6. financials (based on availability)
    • 11.3.3. Essilor
      • 11.3.3.1. Overview,
      • 11.3.3.2. Products,
      • 11.3.3.3. SWOT analysis,
      • 11.3.3.4. Recent developments,
      • 11.3.3.5. strategies,
      • 11.3.3.6. financials (based on availability)
    • 11.3.4. Bausch Health Companies
      • 11.3.4.1. Overview,
      • 11.3.4.2. Products,
      • 11.3.4.3. SWOT analysis,
      • 11.3.4.4. Recent developments,
      • 11.3.4.5. strategies,
      • 11.3.4.6. financials (based on availability)
    • 11.3.5. ZEISS International
      • 11.3.5.1. Overview,
      • 11.3.5.2. Products,
      • 11.3.5.3. SWOT analysis,
      • 11.3.5.4. Recent developments,
      • 11.3.5.5. strategies,
      • 11.3.5.6. financials (based on availability)
    • 11.3.6. HOYA
      • 11.3.6.1. Overview,
      • 11.3.6.2. Products,
      • 11.3.6.3. SWOT analysis,
      • 11.3.6.4. Recent developments,
      • 11.3.6.5. strategies,
      • 11.3.6.6. financials (based on availability)
    • 11.3.7. NIDEK CO., LTD
      • 11.3.7.1. Overview,
      • 11.3.7.2. Products,
      • 11.3.7.3. SWOT analysis,
      • 11.3.7.4. Recent developments,
      • 11.3.7.5. strategies,
      • 11.3.7.6. financials (based on availability)
    • 11.3.8. TOPCON
      • 11.3.8.1. Overview,
      • 11.3.8.2. Products,
      • 11.3.8.3. SWOT analysis,
      • 11.3.8.4. Recent developments,
      • 11.3.8.5. strategies,
      • 11.3.8.6. financials (based on availability)
    • 11.3.9. CooperVision
      • 11.3.9.1. Overview,
      • 11.3.9.2. Products,
      • 11.3.9.3. SWOT analysis,
      • 11.3.9.4. Recent developments,
      • 11.3.9.5. strategies,
      • 11.3.9.6. financials (based on availability)
    • 11.3.10. Other Prominent Players
      • 11.3.10.1. Overview,
      • 11.3.10.2. Products,
      • 11.3.10.3. SWOT analysis,
      • 11.3.10.4. Recent developments,
      • 11.3.10.5. strategies,
      • 11.3.10.6. financials (based on availability)

List of Tables

  • Table 1: Global Ophthalmic Devices Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 2: Global Ophthalmic Devices Market Revenue (USD billion) Forecast, by Surgical, 2021-2034
  • Table 3: Global Ophthalmic Devices Market Revenue (USD billion) Forecast, by Vision Care, 2021-2034
  • Table 4: Global Ophthalmic Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 5: Global Ophthalmic Devices Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Ophthalmic Devices Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 7: North America Ophthalmic Devices Market Revenue (USD billion) Forecast, by Surgical, 2021-2034
  • Table 8: North America Ophthalmic Devices Market Revenue (USD billion) Forecast, by Vision Care, 2021-2034
  • Table 9: North America Ophthalmic Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 10: North America Ophthalmic Devices Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Ophthalmic Devices Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 12: Europe Ophthalmic Devices Market Revenue (USD billion) Forecast, by Surgical, 2021-2034
  • Table 13: Europe Ophthalmic Devices Market Revenue (USD billion) Forecast, by Vision Care, 2021-2034
  • Table 14: Europe Ophthalmic Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 15: Europe Ophthalmic Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Ophthalmic Devices Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 17: Asia Pacific Ophthalmic Devices Market Revenue (USD billion) Forecast, by Surgical, 2021-2034
  • Table 18: Asia Pacific Ophthalmic Devices Market Revenue (USD billion) Forecast, by Vision Care, 2021-2034
  • Table 19: Asia Pacific Ophthalmic Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 20: Asia Pacific Ophthalmic Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Ophthalmic Devices Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 22: Latin America Ophthalmic Devices Market Revenue (USD billion) Forecast, by Surgical, 2021-2034
  • Table 23: Latin America Ophthalmic Devices Market Revenue (USD billion) Forecast, by Vision Care, 2021-2034
  • Table 24: Latin America Ophthalmic Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 25: Latin America Ophthalmic Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Ophthalmic Devices Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 27: Middle East & Africa Ophthalmic Devices Market Revenue (USD billion) Forecast, by Surgical, 2021-2034
  • Table 28: Middle East & Africa Ophthalmic Devices Market Revenue (USD billion) Forecast, by Vision Care, 2021-2034
  • Table 29: Middle East & Africa Ophthalmic Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 30: Middle East & Africa Ophthalmic Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Ophthalmic Devices Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Ophthalmic Devices Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Ophthalmic Devices Market Forecast (USD billion), by Surgical, 2021-2034
  • Figure 4: Global Ophthalmic Devices Market Forecast (USD billion), by Vision Care, 2021-2034
  • Figure 5: Global Ophthalmic Devices Market Value Share (%), by End-user, 2025 & 2034
  • Figure 6: Global Ophthalmic Devices Market Forecast (USD billion), by Hospitals, 2021-2034
  • Figure 7: Global Ophthalmic Devices Market Forecast (USD billion), by Ophthalmic Clinics, 2021-2034
  • Figure 8: Global Ophthalmic Devices Market Forecast (USD billion), by Others, 2021-2034
  • Figure 9: Global Ophthalmic Devices Market Value (USD billion), by Region, 2025 & 2034
  • Figure 10: North America Ophthalmic Devices Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 11: North America Ophthalmic Devices Market Value Share (%), by Product Type, 2025
  • Figure 12: North America Ophthalmic Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 13: North America Ophthalmic Devices Market Value Share (%), by End-user, 2025
  • Figure 14: North America Ophthalmic Devices Market Value (USD billion), By Country, 2025 & 2034
  • Figure 15: North America Ophthalmic Devices Market Value Share (%), By Country, 2025
  • Figure 16: Europe Ophthalmic Devices Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 17: Europe Ophthalmic Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 18: Europe Ophthalmic Devices Market Value Share (%), by End-user, 2025
  • Figure 19: Europe Ophthalmic Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 20: Europe Ophthalmic Devices Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 21: Asia Pacific Ophthalmic Devices Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 22: Asia Pacific Ophthalmic Devices Market Value Share (%), by Product Type, 2025
  • Figure 23: Asia Pacific Ophthalmic Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 24: Asia Pacific Ophthalmic Devices Market Value Share (%), by End-user, 2025
  • Figure 25: Asia Pacific Ophthalmic Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Asia Pacific Ophthalmic Devices Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Latin America Ophthalmic Devices Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 28: Latin America Ophthalmic Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 29: Latin America Ophthalmic Devices Market Value Share (%), by End-user, 2025
  • Figure 30: Latin America Ophthalmic Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 31: Latin America Ophthalmic Devices Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 32: Middle East & Africa Ophthalmic Devices Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 33: Middle East & Africa Ophthalmic Devices Market Value Share (%), by Product Type, 2025
  • Figure 34: Middle East & Africa Ophthalmic Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 35: Middle East & Africa Ophthalmic Devices Market Value Share (%), by End-user, 2025
  • Figure 36: Middle East & Africa Ophthalmic Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Middle East & Africa Ophthalmic Devices Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Global Ophthalmic Devices Market Share (%), By Company, 2025